Filing Details

Accession Number:
0000880984-22-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-18 19:05:42
Reporting Period:
2022-11-16
Accepted Time:
2022-11-18 19:05:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1719406 Nrx Pharmaceuticals Inc. NRXP Pharmaceutical Preparations (2834) 822844431
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1864534 C. Daniel Javitt 1201 North Market Street
Suite 111
Wilmington DE 19801
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-16 133,719 $1.02 9,689,982 No 4 S Indirect by Glytech LLC
Common Stock Disposition 2022-11-17 33,018 $1.05 9,656,964 No 4 S Indirect by Glytech LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Glytech LLC
No 4 S Indirect by Glytech LLC
Footnotes
  1. Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
  2. Held by Glytech LLC of which the Reporting Person is the sole owner.